senate Bill S2058A

Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing for use in tissue typing for bone marrow testing

download pdf

Sponsor

Co-Sponsors

view all co-sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 10 / Jan / 2013
    • REFERRED TO INSURANCE
  • 11 / Mar / 2013
    • NOTICE OF COMMITTEE CONSIDERATION - REQUESTED
  • 22 / Apr / 2013
    • REPORTED AND COMMITTED TO HEALTH
  • 08 / Jan / 2014
    • REFERRED TO INSURANCE
  • 13 / Jan / 2014
    • AMEND AND RECOMMIT TO INSURANCE
  • 13 / Jan / 2014
    • PRINT NUMBER 2058A

Summary

Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A3031A
Versions:
S2058
S2058A
Legislative Cycle:
2013-2014
Current Committee:
Senate Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in Previous Legislative Cycles:
2011-2012: S4350A, A6459A
2009-2010: A4988, A4988
2007-2008: A4084, A4084

Sponsor Memo

BILL NUMBER:S2058A

TITLE OF BILL: An act to amend the insurance law, in relation to
requiring policies and contracts of insurance providing hospital,
surgical, or medical care coverage to include coverage for human
leukocyte antigen testing

PURPOSE: Requires certain health insurance policies and contracts to
provide coverage for human leukocyte antigen testing for use in tissue
typing for bone marrow testing.

SUMMARY OF PROVISIONS: Amends the insurance law by adding a new
paragraph 30 to subsection (i) of section 3216, adding a new paragraph
19 to subsection (1) of section 3221, and adding a new subsection (oo)
to section 4303

EXISTING LAW: This legislation will amend existing law to include this
new provision.

JUSTIFICATION: Each year thousands of people require bone marrow
transplants to treat diseases such as lymphomas, leukemia's, anemia's,
immune deficiency disorders, multiple myeloma and solid tumors. Bone
marrow transplants replenish stem cells which are found in greatest
concentrations within the bone marrow.

The problem currently faced by patients in need of stem cells is that
of finding a proper match of human leukocyte antigens. In order to
facilitate the vast number of people who suffer from the life
threatening blood disease, a national registry has been set up which
records typing of antigens for potential donors. At the present time,
bone marrow donors are required to pay a fee up to $75 in order to
perform the test and have their name placed on the national donor
list. Certainly, people in New York are more likely to be members of
the registry if they do not have to pay a fee and if tissue typing is
more accessible.

This bill would require health insurance companies to cover the tissue
typing fee. The end result would be an increase in the number of bone
marrow donors in the registry and a greater likelihood to find
possible donor matches.

LEGISLATIVE HISTORY: A.9761 - 1999-2000 A.1186 - 2001-2002 A.777 -
2003-2004 A.3622 - 2005-2006 A.4084 - 2007-2008 A.4988 - 2009-2010
03/30/11 REFERRED TO INSURANCE 01/04/12 REFERRED TO INSURANCE 01/10/13
REFERRED TO INSURANCE 04/22/13 REFERRED TO Health 01/08/14 REFERRED TO
INSURANCE

FISCAL IMPLICATIONS: None

LOCAL FISCAL IMPLICATIONS: None

EFFECTIVE DATE: This act shall take effect on the first of January
next succeeding the date on which it shall have become a law and shall
apply to all policies and contracts issued, renewed, modified,
altered, or amended on or after such date; provided, however, that any
rules or regulations necessary for the implementation of this act on
its effective date shall be promulgated, and any other means necessary


for the implementation of this act on its effective date shall be
taken, on or before such effective date.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 2058--A

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                            January 10, 2013
                               ___________

Introduced  by Sens. LATIMER, CARLUCCI, DILAN, ESPAILLAT, KENNEDY, MONT-
  GOMERY, PARKER, SAMPSON -- read twice and ordered  printed,  and  when
  printed  to  be committed to the Committee on Insurance -- recommitted
  to the Committee on Insurance in accordance with Senate Rule 6, sec. 8
  -- committee discharged, bill amended, ordered  reprinted  as  amended
  and recommitted to said committee

AN ACT to amend the insurance law, in relation to requiring policies and
  contracts  of  insurance providing hospital, surgical, or medical care
  coverage to include coverage for human leukocyte antigen testing

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
amended by adding a new paragraph 30 to read as follows:
  (30) EVERY POLICY WHICH PROVIDES HOSPITAL, SURGICAL, OR  MEDICAL  CARE
COVERAGE OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT
FOR DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR HUMAN LEUKOCYTE
ANTIGEN TESTING, ALSO REFERRED TO AS HISTOCOMPATIBLE LOCUS ANTIGEN TEST-
ING, FOR A, B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE TYPING FOR BONE
MARROW TESTING.
  S 2. Subsection (1) of section 3221 of the insurance law is amended by
adding a new paragraph 19 to read as follows:
  (19) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN
THIS  STATE  WHICH PROVIDES HOSPITAL, SURGICAL, OR MEDICAL CARE COVERAGE
SHALL  PROVIDE  COVERAGE  FOR  HUMAN  LEUKOCYTE  ANTIGEN  TESTING,  ALSO
REFERRED  TO  AS HISTOCOMPATIBLE LOCUS ANTIGEN TESTING, FOR A, B, AND DR
ANTIGENS FOR UTILIZATION IN  TISSUE  TYPING  FOR  BONE  MARROW  TESTING,
EXCEPT  THAT  THIS  PROVISION  SHALL  NOT APPLY TO A POLICY WHICH COVERS
PERSONS EMPLOYED IN MORE THAN ONE STATE  OR  THE  BENEFIT  STRUCTURE  OF
WHICH WAS THE SUBJECT OF COLLECTIVE BARGAINING AFFECTING PERSONS WHO ARE
EMPLOYED IN MORE THAN ONE STATE.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD05133-02-4

S. 2058--A                          2

  S  3.  Section  4303  of  the insurance law is amended by adding a new
subsection (oo) to read as follows:
  (OO)  A  MEDICAL  EXPENSE  INDEMNITY  CORPORATION,  A HOSPITAL SERVICE
CORPORATION OR A HEALTH SERVICE CORPORATION WHICH PROVIDES COVERAGE  FOR
HOSPITAL,  SURGICAL,  OR  MEDICAL  CARE SHALL PROVIDE COVERAGE FOR HUMAN
LEUKOCYTE ANTIGEN TESTING, ALSO REFERRED  TO  AS  HISTOCOMPATIBLE  LOCUS
ANTIGEN  TESTING,  FOR  A,  B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE
TYPING FOR BONE MARROW TESTING, EXCEPT THAT  THIS  PROVISION  SHALL  NOT
APPLY TO A CONTRACT WHICH COVERS PERSONS EMPLOYED IN MORE THAN ONE STATE
OR THE BENEFIT STRUCTURE OF WHICH WAS THE SUBJECT OF COLLECTIVE BARGAIN-
ING AFFECTING PERSONS WHO ARE EMPLOYED IN MORE THAN ONE STATE.
  S 4.  This act shall take effect on the first of January next succeed-
ing  the date on which it shall have become a law and shall apply to all
policies and contracts issued, renewed, modified, altered, or amended on
or after such effective date. Effective immediately any rules  or  regu-
lations  necessary  for  the implementation of this act on its effective
date shall be promulgated, and any  other  measures  necessary  for  the
implementation  of  this act on its effective date shall be taken, on or
before such effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.